Clinical Laboratory Testing Volume 1: Reagents and Instruments

Table of Contents

1. Overview

• 1.1 Objectives of the Report
• 1.2 Methodology
• 1.3 Scope of the Report
• 1.4 Executive Summary

2. IVD Clinical Laboratory Market

• 2.1 Introduction
• 2.2 Independent Clinical Labs
  • 2.2.1 Key Players for Independent Clinical Labs
  • 2.2.2 Quest and LabCorp
  • 2.2.3 Competitive Advantages at Quest and LabCorp
  • 2.2.4 Competitive Disadvantages of Quest and LabCorp
  • 2.2.5 Revenue Growth of Quest and LabCorp
  • 2.2.6 Sector Consolidation
  • 2.2.7 Additional Independent Clinical Laboratories
• 2.3 Hospital Market
  • 2.3.1 Hospital Market Overview
  • 2.3.2 Hospital Lab Testing Drivers
  • 2.3.3 Evaluation Models of Laboratory Testing
  • 2.3.4 GPOs and IDNs
  • 2.3.5 Distributors
  • 2.3.6 Clinical Lab Testing Suppliers
  • 2.3.7 European Hospital Purchasing Practices
  • 2.3.8 Changes in Hospital Funding
  • 2.3.9 European Group Purchasing
• 2.4 POL Market
• 2.5 IVD Industry
  • 2.5.1 Industry Overview
  • 2.5.2 IVD Industry Leading Players Comparison and Review
  • 2.5.3 Biotechnology Reagents and Supplies
    • 2.5.3.1 Vendor Quality Assurance
    • 2.5.3.2 Partnership Support
    • 2.5.3.3 Protecting Supply of Raw Materials
    • 2.5.3.4 Selecting a Second Source for Chemicals
    • 2.5.3.5 Cost Analysis for Reagent Manufacture
    • 2.5.3.6 Outsourcing Production of Reagents
  • 2.5.4 The Fastest Growing IVD Reagent Markets
  • 2.5.5 Automated Instrumentation
  • 2.5.6 High Growth Applications Spur Industry Growth
• 2.6 Automated Instrument Platforms Evolution
• 2.7 Reagents and Supplies Market for Clinical Lab Instruments
• 2.8 Spending for Clinical Laboratory Testing
  • 2.8.1 Reimbursement Pressure
  • 2.8.2 Medicare Part B Spending Trends
  • 2.8.3 Strategies for Revenue Growth

3. IVD Clinical Laboratory Market

• 3.1 Markets
  • 3.1.1 Global Markets
  • 3.1.2 Global Drivers of Clinical Laboratory Testing
  • 3.1.3 Global Outlook
  • 3.1.4 U.S. Market
  • 3.1.5 European IVD Market
    • 3.1.5.1 German Clinical Laboratory Diagnostic Markets
    • 3.1.5.2 U.K. Clinical Laboratory Testing Diagnostic Market
      • 3.1.5.2.1 U.K. Competitive Analysis
      • 3.1.5.2.2 U.K. Market Access
    • 3.1.5.3 French Clinical Laboratory Diagnostic Testing Market
    • 3.1.5.4 Italian Clinical Laboratory Diagnostic Market
    • 3.1.5.5 Spanish Clinical Laboratory Diagnostic Market
    • 3.1.5.6 Finnish Clinical Laboratory Market
    • 3.1.5.7 Turkish Clinical Laboratory Market
    • 3.1.5.8 Belgium Clinical Laboratory Diagnostic Market
    • 3.1.5.9 Swiss Clinical Laboratory Diagnostic Market
    • 3.1.5.10 Dutch Clinical Laboratory Diagnostic Market
    • 3.1.5.11 Portuguese Clinical Laboratory Diagnostic Market
    • 3.1.5.12 Austrian Clinical Laboratory Diagnostic Market
    • 3.1.5.13 Greek Clinical Laboratory Diagnostic Market
    • 3.1.5.14 Polish Clinical Laboratory Diagnostic Market
    • 3.1.5.15 Romanian Clinical Laboratory Diagnostic Market
    • 3.1.5.16 Czech Republic Clinical Laboratory Diagnostic Market
    • 3.1.5.17 Swedish Clinical Laboratory Diagnostic Market
    • 3.1.5.18 Norwegian Clinical Laboratory Diagnostic Market
    • 3.1.5.19 Irish Clinical Laboratory Diagnostic Market
    • 3.1.5.20 Hungarian Clinical Laboratory Diagnostic Market
    • 3.1.5.21 Bulgarian Clinical Laboratory Diagnostic Market
    • 3.1.5.22 Slovakian Clinical Laboratory Diagnostic Market
    • 3.1.5.23 Lithuanian Clinical Laboratory Diagnostic Market
    • 3.1.5.24 Latvian Clinical Laboratory Diagnostic Market
    • 3.1.5.25 Estonian Clinical Laboratory Diagnostic Market
    • 3.1.5.26 Slovenian Clinical Laboratory Diagnostic Market
  • 3.1.6 Asian Markets
    • 3.1.6.1 Indian Clinical Laboratory Diagnostic Market
      • 3.1.6.1.1 Indian IVD Testing Industry
    • 3.1.6.2 Japanese Clinical Laboratory Testing Market
    • 3.1.6.3 Chinese Clinical Laboratory Market
  • 3.1.7 Clinical Laboratory Smaller Country Markets
    • 3.1.7.1 Canadian Clinical Laboratory Market
    • 3.1.7.2 Brazilian Clinical Laboratory Market
    • 3.1.7.3 Australian Clinical Laboratory Market
  • 3.1.8 ROW Clinical Laboratory Testing Market
  • 3.1.9 Overview of Asian Healthcare Market
    • 3.1.9.1 Singapore
    • 3.1.9.2 Malaysia
    • 3.1.9.3 Thailand
    • 3.1.9.4 Indonesia
    • 3.1.9.5 Philippines
    • 3.1.9.6 South Korea
    • 3.1.9.7 India
    • 3.1.9.8 Hong Kong
    • 3.1.9.9 Taiwan
  • 3.1.10 Overview of the Latin American Diagnostics Market
• 3.2 Clinical Laboratory Sector
  • 3.2.1 Worldwide IVD Sales
    • 3.2.1.1 POLs
  • 3.2.2 Industry Players
    • 3.2.2.1 Manufacturing Companies
  • 3.2.3 Market Specialization
  • 3.2.4 Revenue and Reimbursement
  • 3.2.5 Companies
• 3.3 Outlook for Clinical Laboratory Testing
  • 3.3.1 Long-Term Changes
  • 3.3.2 Market Drivers
  • 3.3.3 The Limits to Growth
  • 3.3.4 Hot Sectors in the IVD Market
  • 3.3.5 Key Technologies
  • 3.3.6 Conclusion

4. Clinical Laboratory Instrument Market by Sector

• 4.1 Chemistry Analyzers
  • 4.1.1 Ultra-Large Throughput Laboratory Analyzers
  • 4.1.2 Large-Throughput Analyzers
  • 4.1.3 Mid-Size Clinical Laboratory Analyzers
  • 4.1.4 Laboratory Analyzers for the Small Volume Market
• 4.2 Immunochemistry Analyzers
  • 4.2.1 Large Immunochemistry Analyzers
  • 4.2.2 Small Immunoassay Analyzers
• 4.3 Hematology Analyzers
• 4.4 POCT
  • 4.4.1 U.S. POC Markets
  • 4.4.2 European POCT Market
    • 4.4.2.1 German POC Diagnostic Markets
    • 4.4.2.2 U.K. POCT Diagnostic Market
      • 4.4.2.2.1 U.K. Market Statistics
      • 4.4.2.2.2 U.K. Competitive Analysis
      • 4.4.2.2.3 U.K. Market Access
    • 4.4.2.3 French POC Diagnostic Market
    • 4.4.2.4 Italian POC Diagnostic Market
    • 4.4.2.5 Spanish POC Diagnostic Market
    • 4.4.2.6 Scandinavian POC Market
  • 4.4.3 Japanese POCT Market
  • 4.4.4 Chinese POC Market
  • 4.4.5 Canadian POC Market
  • 4.4.6 Brazilian POC Market
  • 4.4.7 Turkish POC Market
  • 4.4.8 Australian POC Market
• 4.5 ROW POCT Market
• 4.6 Cytology Testing
• 4.7 Microbiology Testing
• 4.8 Serology Testing
• 4.9 Esoteric Testing
• 4.10 Anatomic Pathology
• 4.11 Drug Testing

5. Important Technology Trends in IVD Instrumentation and Reagents

• 5.1 Technology Innovations in Instrument and Reagent Development
• 5.2 Sensor Systems for Diagnostic Applications
• 5.3 Glucose Measurements
• 5.4 Glucose Test Methods
• 5.5 Cholesterol Measurements
• 5.6 The New Paradigm
• 5.7 Consolidated Workstations
• 5.8 Automation in the Laboratory
• 5.9 Laboratory Information Systems
• 5.10 New User-friendly Interfaces
• 5.11 Biosensor Technology
• 5.12 Data-Management Issues
  • 5.12.1 Wireless LANs
  • 5.12.2 Cepheid' s POC GBS and BCR/ABL Tests
  • 5.12.3 Data and Workflow Management Systems
  • 5.12.4 Beckman Central Command

6. Business Trends in the Clinical Laboratory Analyzer and Reagents Market

• 6.1 Key Market Developments
  • 6.1.1 Decreasing Revenue from Traditional IVD Markets
  • 6.1.2 High Growth in POCT and Molecular Diagnostics Arena
  • 6.1.3 Move Away from Traditional Kit Testing Methods
  • 6.1.4 Integrated Analytical Systems
  • 6.1.5 Regulatory Changes
  • 6.1.6 Development of a Two-Tier Industry Structure
  • 6.1.7 Labor Costs
  • 6.1.8 Increasing Value of Companies with High-Margin Technology Platforms
  • 6.1.9 The Joining of IVD Testing and Computer Technology
  • 6.1.10 User-Friendly User Interfaces
• 6.2 Sector Consolidation
  • 6.2.1 IVD Company Consolidation
  • 6.2.2 Lab Company Consolidation
    • 6.2.2.1 Acquisition Pricing
    • 6.2.2.2 A Closer Look at Six Big Lab Deals
• 6.3 Diagnostic Testing Growth Trends
• 6.4 Reagent and Hardware Business in Japan
• 6.5 New Products
• 6.6 Acquisition, License Agreements, Internal Development and Partnerships
• 6.7 Product Testing Depth in Clinical Laboratory Testing
• 6.8 Government Regulation of IVD Devices
  • 6.8.1 U.S. Regulation
    • 6.8.1.1 Importing Medical Devices into the U.S.
    • 6.8.1.2 Exporting Medical Devices from the U.S.
  • 6.8.2 U.K. Regulation
  • 6.8.3 E.U. Regulation
    • 6.8.3.1 France
  • 6.8.4 Japanese Regulation
  • 6.8.5 Korean Regulation
  • 6.8.6 Chinese Regulation
• 6.9 Increased Market Penetration
• 6.10 Costs of Doing Business in Europe
• 6.11 Drivers of European Diagnostics Testing
• 6.12 European Reimbursement Practices
• 6.13 Cost Containment in Europe
• 6.14 Hospital Outreach Programs
• 6.15 Electronic Procurement: New Challenges
• 6.16 Competition for Supply Chain Management Solutions
• 6.17 E-Commerce in the Hospital Supply Chain
  • 6.17.1 Drivers of E-Commerce Solutions
  • 6.17.2 Barriers to E-Commerce Solutions
• 6.18 Top Trends in Laboratory Business Practices
• 6.19 The Value of the New Diagnostics
• 6.20 Converging Technologies-Drugs and Diagnostic Tests Combine for Improved Healthcare
• 6.21 Emerging Technologies in the Downstream Manufacture of Bio-Materials
• 6.22 GMP Readiness
• 6.23 Harnessing Human Resource Capabilities and IT Prowess: Biotechnology in the Future
• 6.24 Partnering with Patient-Based Organizations to Achieve Patient Health Goals
• 6.25 Rumors of the Platform Company' s Demise are Greatly Exaggerated
• 6.26 Who' s Going to Pay for It?

7. Company Profiles

• 7.1 Abaxis
• 7.2 Abbott Diagnostics
• 7.3 Adaltis, Inc.
• 7.4 Alfa Wasserman, Inc. (formerly Electro-Nucleonics, Inc. and Schiapparelli Biosystems, Inc.)
• 7.5 Awareness Technology
• 7.6 Bayer Diagnostics
• 7.7 Beckman Coulter, Inc.
• 7.8 Bio-Reference Laboratories, Inc.
• 7.9 Clarient, Inc.
• 7.10 Dade Behring, Inc.
• 7.11 Enzo Biochem, Inc.
• 7.12 Genomic Health, Inc.
• 7.13 Hitachi
• 7.14 Horiba Ltd.
• 7.15 JEOL Ltd.
• 7.16 LabCorp
• 7.17 Medtox Scientific, Inc.
• 7.18 Monogram Biosciences, Inc.
• 7.19 Myriad Genetics, Inc.
• 7.20 Nova Biomedical
• 7.21 Olympus America, Inc. Diagnostic Systems Division
• 7.22 Ortho-Clinical Diagnostics, a J&J Company
• 7.23 Psychemedics Corporation
• 7.24 Quest Diagnostics, Inc.
• 7.25 Roche Diagnostics Corp.
• 7.26 Shimadzu
• 7.27 Sysmex Corporation
• 7.28 Thermo Fisher Scientific, Inc.
• 7.29 Vital Scientific, NV

LIST OF FIGURES

• Figure 2.1: Clinical Laboratory Testing Sector Providers
• Figure 2.2: Part B Spending on Clinical Laboratory Services, 1991-2005
• Figure 3.1: European IVD Market by Clinical Specialty
• Figure 3.2: Chinese IVD Market, 1995-2004
• Figure 3.3: Annual Worldwide IVD Market Growth, 2003-2005
• Figure 3.4: POL Revenue, 2000-2006
• Figure 3.5: Unweighted Average Medicare Reimbursement for Ten Most Common POL Tests, 2002 vs. 2006
• Figure 3.6: Total Number of Non-Waived POLs, 2000-2006
• Figure 3.7: Number of New Tests Granted CLIA-Waived Status, 2000-2006
• Figure 3.8: High-Volume Waived Tests
• Figure 3.9: U.S. Revenue for Six Largest IVD Vendors, 2005
• Figure 3.10: U.S. Revenue Change for Six Largest IVD Vendors, 2005
• Figure 6.1: Average Revenue-Multiple Paid to Acquire Labs, 2000-2006
• Figure 6.2: Hospital Market Share for Outreach Programs

LIST OF TABLES

• Table 2.1: Total U.S. Clinical Laboratory Revenue from Third Party and Direct Payment, 2005-2012
• Table 2.2: U.S. Clinical Laboratory Diagnostic Test Market Segments, 2005
• Table 2.3: Independent Commercial Laboratory Testing Market Value, 2005-2012
• Table 2.4: Independent Commercial Laboratory Testing Test Volume, 2005-2012
• Table 2.5: Leading U.S. Reference Laboratories Grouped by Market Capitalization, 2006
• Table 2.6: Revenue Growth at Quest Diagnostics, 2000-2006
• Table 2.7: Revenue Growth at LabCorp, 2000-2006
• Table 2.8: Quest Diagnostics Revenue from Managed Care Contracts, 2004-2006
• Table 2.9: LabCorp Revenue from Managed Care Contracts, 2004-2006
• Table 2.10: Quest' s Total Volume of Requisitions and Net Revenues from Clinical Laboratory Testing, 2005
• Table 2.11: Number of Hospital Based Clinical Laboratory Tests in the U.S., 2002-2008
• Table 2.12: European Cardiovascular Disease Management Expenditures, 2003-2010
• Table 2.13: U.S. Doctor' s Office Lab Test Dollar Volume and Growth Rates, 2006
• Table 2.14: Worldwide Alternate Site Clinical Lab Instrument and Reagents Sales, 2005-2012
• Table 2.15: Top IVD Manufacturers, 2005
• Table 2.16: Products Marketed by Abbott in the Diagnostic Market
• Table 2.17: Prodesse' s ASRs
• Table 2.18: Hospital Laboratory Share of Part B Medicare Spending, 1996-2005
• Table 2.19: Medicare Spending on Clinical Lab Services, 1991-2005
• Table 2.20: Medicare Part B Spending Per Medicare Enrollee, 1998-2005
• Table 2.21: Allowed Charges for Top 25 Clinical Laboratory Procedures, 2005
• Table 3.1: Worldwide IVD Testing Market, 2006
• Table 3.2: Worldwide Distribution of IVD Testing, 2006
• Table 3.3: Global Clinical Laboratory Market Sales, 1998-2010
• Table 3.4: Top 15 IVD Manufacturers' Worldwide Revenue
• Table 3.5: U.S. Clinical Laboratory Testing Market, 2003-2012
• Table 3.6: U.S. Clinical Laboratory Diagnostic Test Market Segments, 2006
• Table 3.7: U.S. Clinical Laboratory Diagnostic Testing Reagents and Instruments Market by Analyte, 2006
• Table 3.8: U.S. Individual Clinical Chemistry Laboratory Diagnostic Test Markets, 2006
• Table 3.9: European Clinical Laboratory Testing IVD Reagents and Instruments Market, 2000-2012
• Table 3.10: European Clinical Laboratory Diagnostic Testing Reagents and Instruments Market by Analyte, 2006
• Table 3.11: European Clinical Chemistry Testing Reagents and Instruments Market, 2006
• Table 3.12: European Clinical Laboratory Testing Diagnostics by Country Market, 2006
• Table 3.13: European Rapid POCT by Country Market, 2006
• Table 3.14: European Patient Self Testing OTC Diagnostics by Country Market, 2006
• Table 3.15: German Clinical Laboratory Testing Diagnostics Products Market Sales, 2003-2012
• Table 3.16: German Clinical Reagents and Instruments Market, 2003
• Table 3.17: U.K. Clinical Laboratory Diagnostics Products Market Sales, 2003-2012
• Table 3.18: U.K. Clinical Reagents and Instruments Market, 2006
• Table 3.19: Major U.K. IVD Manufacturers
• Table 3.20: U.S. IVD Manufacturers Doing Business in the U.K.
• Table 3.21: Other European Companies that Manufacture IVD Products in the U.K.
• Table 3.22: French Clinical IVD Testing Diagnostics Products Market Sales, 2003-2012
• Table 3.23: French Clinical Reagents and Instruments Market, 2006
• Table 3.24: Italian Laboratory Diagnostics Products Market Sales, 2003-2012
• Table 3.25: Italian Clinical Reagents and Instruments Market, 2006
• Table 3.26: Spanish Clinical Laboratory Diagnostics Products Market Sales, 2003-2012
• Table 3.27: Spanish Clinical Reagents and Instruments Market, 2006
• Table 3.28: Finnish Clinical Laboratory Diagnostics Products Market Sales, 2003-2012
• Table 3.29: Finnish Clinical Reagents and Instruments Market, 2006
• Table 3.30: Turkish Clinical Laboratory Testing Market, 2003-2012
• Table 3.31: Belgium Clinical Laboratory Diagnostics Products Market Sales, 2003-2012
• Table 3.32: Belgium Clinical Reagents and Instruments Market, 2006
• Table 3.33: Swiss Clinical Laboratory Diagnostics Products Market Sales, 2003-2012
• Table 3.34: Swiss Clinical Reagents and Instruments Market, 2006
• Table 3.35: Dutch Clinical Laboratory Diagnostics Products Market Sales, 2003-2012
• Table 3.36: Dutch Clinical Reagents and Instruments Market, 2006
• Table 3.37: Portuguese Clinical Laboratory Diagnostics Products Market Sales, 2003-2012
• Table 3.38: Portuguese Clinical Reagents and Instruments Market, 2006
• Table 3.39: Austrian Clinical Laboratory Diagnostics Products Market Sales, 2003-2012
• Table 3.40: Austrian Clinical Reagents and Instruments Market, 2006
• Table 3.41: Greek Clinical Laboratory Diagnostics Products Market Sales, 2003-2012
• Table 3.42: Greek Clinical Reagents and Instruments Market, 2006
• Table 3.43: Polish Clinical Laboratory Diagnostics Products Market Sales, 2003-2012
• Table 3.44: Polish Clinical Reagents and Instruments Market, 2006
• Table 3.45: Romanian Clinical Laboratory Diagnostics Products Market Sales, 2003-2012
• Table 3.46: Romanian Clinical Reagents and Instruments Market, 2006
• Table 3.47: Czech Republic Clinical Laboratory Diagnostics Products Market Sales, 2003-2012
• Table 3.48: Swedish Clinical Laboratory Diagnostics Products Market Sales, 2003-2012
• Table 3.49: Norwegian Clinical Laboratory Diagnostics Products Market Sales, 2003-2012
• Table 3.50: Irish Clinical Laboratory Diagnostics Products Market Sales, 2003-2012
• Table 3.51: Hungarian Clinical Laboratory Diagnostics Products Market Sales, 2003-2012
• Table 3.52: Bulgarian Clinical Laboratory Diagnostics Products Market Sales, 2003-2012
• Table 3.53: Slovakian Clinical Laboratory Diagnostics Products Market Sales, 2003-2012
• Table 3.54: Lithuanian Clinical Laboratory Diagnostics Products Market Sales, 2003-2012
• Table 3.55: Latvian Clinical Laboratory Diagnostics Products Market Sales, 2003-2012
• Table 3.56: Estonian Clinical Laboratory Diagnostics Products Market Sales, 2003-2012
• Table 3.57: Slovenian Clinical Laboratory Diagnostics Products Market Sales, 2003-2012
• Table 3.58: Indian IVD Market for Instruments and Reagents, 2004-2012
• Table 3.59: Number of Automated Clinical Labs in India, 2004-2012
• Table 3.60: Indian IVD Market, 2006
• Table 3.61: Market Sales of IVD Equipment and Reagents by Company in India, 2004 and 2005
• Table 3.62: Japanese Clinical Laboratory Testing Instrument and Reagents Market, 2003-2012
• Table 3.63: Chinese Clinical Laboratory Diagnostics Products Market Sales, 2003-2012
• Table 3.64: Chinese IVD Market
• Table 3.65: Proportion of Medical Expenses Paid Privately
• Table 3.66: Chinese International IVD Manufacturers
• Table 3.67: Chinese Domestic IVD Manufacturers
• Table 3.68: Chinese IVD Distributors
• Table 3.69: Canadian Clinical Laboratory Testing Market, 2000-2008
• Table 3.70: Brazilian Clinical Laboratory Testing Market, 2000-2008
• Table 3.71: Australian Clinical Laboratory Testing Market, 2000-2008
• Table 3.72: ROW Clinical Laboratory Testing Market, 2000-2008
• Table 3.73: Number of Clinical Laboratories in Latin America
• Table 3.74: Twenty Most Common Laboratory Tests Offered at Family Physician Offices
• Table 3.75: Important New Waived Tests
• Table 3.76: Principal Marketers of Automated Clinical Laboratory Instruments
• Table 4.1: Ultra-Large Clinical Laboratory Analyzers
• Table 4.2: JEOL Analyzer Comparison
• Table 4.3: Large Clinical Laboratory Analyzers
• Table 4.4: Mid-size Clinical Laboratory Analyzers
• Table 4.5: Small Clinical Laboratory Analyzers
• Table 4.6: Large Immunochemistry Analyzers
• Table 4.7: Small Immunoassay Analyzers
• Table 4.8: Linearity and Precision of Abbott CELL-DYN Hematology Analyzers
• Table 4.9: Accuracy of the Automated Differential of Abbott CELL-DYN Analyzers
• Table 4.10: Linearity and Precision of Bayer Hematology Analyzers
• Table 4.11: Accuracy of the Automated Differential of Bayer Hematology Analyzers
• Table 4.12: Linearity and Precision of Beckman Coulter Hematology Instruments
• Table 4.13: Accuracy of the Automated Differential of Beckman Coulter Hematology Analyzers
• Table 4.14: Linearity and Precision of Horiba ABX Hematology Analyzers
• Table 4.15: Accuracy of the Horiba ABX Hematology Analyzers
• Table 4.16: Linearity and Precision of Sysmex Hematology Analyzers
• Table 4.17: Accuracy of the Sysmex Hematology Analyzers
• Table 4.18: Comparison of Linearity and Precision of Top-of-the-Line Hematology Analyzers
• Table 4.19: Comparison of Accuracy of the Top-of-the-Line Hematology Analyzers
• Table 4.20: Hematology Analyzers with a Five-Part WBC Differential
• Table 4.21: Hematology Analyzers with a Three-Part WBC Differential
• Table 4.22: POCT
• Table 4.23: Number of ER Visits in U.S. Hospitals, 1996-2005
• Table 4.24: Number of POCT in U.S., 2000-2011
• Table 4.25: Global POC Revenues, 1998-2008
• Table 4.26: Worldwide Distribution of POCT, 2005
• Table 4.27: U.S. POCT Market, 2000-2011
• Table 4.28: U.S. Clinical Diagnostic Test Market Segments, Revenue from Clinical Laboratory Testing, 2005
• Table 4.29: U.S. POCT by Distribution Location, 2005
• Table 4.30: U.S. Clinical Diagnostic POCT and Rapid Test Market Segments, 2005
• Table 4.31: Drivers of European Diagnostics Testing
• Table 4.32: Regional Comparison of Healthcare and IVD for Eastern Europe
• Table 4.33: European IVD Reagent Testing Market, 2000-2012
• Table 4.34: European Testing Diagnostics Market, 2004
• Table 4.35: Top Dozen Country IVD Testing Markets and POC Share, 2004
• Table 4.36: German POCT Diagnostics Products Market Sales, 2002-2007
• Table 4.37: German Patient Care Central Lab Test Market, 2000-2008
• Table 4.38: German Alternate Site Testing Market (POL), 2000-2008
• Table 4.39: German Hospital POC Market, 2000-2008
• Table 4.40: German Clinical Diagnostic Test Market Segments; Sales from Clinical Laboratory Testing, 2004
• Table 4.41: German Clinical Diagnostic Rapid Test Market Segments
• Table 4.42: U.K. POC Diagnostics Products Market Sales, 1998-2007
• Table 4.43: Major U.K. IVD Manufacturers
• Table 4.44: U.S. IVD Manufacturers Doing Business in the U.K.
• Table 4.45: Other European Companies that Manufacture IVD Products in the U.K.
• Table 4.46: French POC Diagnostics Products Market Sales, 1998-2007
• Table 4.47: Italian POC Diagnostics Products Market Sales, 1998-2007
• Table 4.48: Spanish POC Diagnostics Products Market Sales, 1998-2007
• Table 4.49: Scandinavian POC Diagnostics Products Market Sales, 2000-2008
• Table 4.50: Japanese POCT Market, 2000-2008
• Table 4.51: Chinese POC Diagnostics Products Market Sales, 2000-2008
• Table 4.52: Canadian POCT Market, 2000-2008
• Table 4.53: Brazilian POCT Market, 2000-2008
• Table 4.54: Turkish POCT Market, 2000-2008
• Table 4.55: Australian POCT Market, 2000-2008
• Table 4.56: ROW POCT Market, 2000-2007
• Table 4.57: PAP Tests in Top European Markets
• Table 4.58: PAP Tests in Top Asian Markets
• Table 5.1: Normal Glucose Values-Fasting State
• Table 5.2: Applications for Wireless LAN Technology
• Table 7.1: Products Marketed by Abbott in the Diagnostics Market
• Table 7.2: Products Marketed by Dade Behring in the Diagnostics Market
• Table 7.3: Clinically Significant Tests Available From Dade
• Table 7.4: Comparison of JEOL Analyzers
• Table 7.5: The VITROS ECiQ Immunodiagnostic System
• Table 7.6: Sysmex Marketing Summary for China